Compare Ology Bioservices vs Prism Pharmaceuticals
Customers evaluate the quality of Ology Bioservices's products using the following success metrics.
Overview
Ology Bioservices is 25 yrs old and is based in United States.
Ology Bioservices is a privately held biopharmaceutical company with a major focus on developing a diversified proprietary pipeline of products having both biodefense and medical applications. Products under development include biodefense medical countermeasures, CNS, wound healing, addiction and pain, oncology, anti-infectives, vaccines and orthopedics. The Company has one FDA cleared injectable biologic, NanoFUSE DBM, used by orthopedic surgeons as bone graft filler. Nanotherapeutics has in-house cGMP manufacturing, formulation, and expertise in pre-clinical and clinical product development as well as clinical trial management to support its products. On April 12th, 2021, Ology Bioservices was acquired by RESILIENCE. The terms of the transaction were not disclosed.
Prism Pharmaceuticals is 20 yrs old and is based in United States.
Prism Pharmaceuticals is an acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products.
Demo Video
Leadership
Brandon Brega (Chief Operating Officer)
Cameron Durrant (Founder)
Investors
Resilience, U.S. Department of Defense
Baxter, EW Healthcare Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Ology Bioservices has not claimed their profile.
Work for Ology Bioservices? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Ology Bioservices?
Claim your profile now.
Information not available because Prism Pharmaceuticals has not claimed their profile.
Work for Prism Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Prism Pharmaceuticals?
Claim your profile now.